id todo:paper_00150282_v90_n4SUPPL_p1511_Quintana
record_format dspace
spelling todo:paper_00150282_v90_n4SUPPL_p1511_Quintana2023-10-03T14:13:29Z Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model Quintana, R. Kopcow, L. Marconi, G. Young, E. Yovanovich, C. Paz, D.A. cyclooxygenase-2 inhibitor meloxicam Ovarian hyperstimulation syndrome VEGF arachidonic acid chorionic gonadotropin cyclooxygenase 1 cyclooxygenase 2 cyclooxygenase 2 inhibitor estradiol icosanoid meloxicam prostaglandin rofecoxib seric gonadotropin vasculotropin vasculotropin receptor 1 vasculotropin receptor 2 animal experiment animal model animal tissue article controlled study drug mechanism female granulosa cell immunohistochemistry immunoreactivity nonhuman organ weight ovary follicle ovary hyperstimulation ovary weight priority journal protein expression rat stroma cell Wistar rat Animals Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Down-Regulation Female Gene Expression Humans Incidence Organ Size Ovarian Hyperstimulation Syndrome Ovary Rats Rats, Wistar Thiazines Thiazoles Vascular Endothelial Growth Factor A Fil:Yovanovich, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Paz, D.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00150282_v90_n4SUPPL_p1511_Quintana
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic cyclooxygenase-2 inhibitor
meloxicam
Ovarian hyperstimulation syndrome
VEGF
arachidonic acid
chorionic gonadotropin
cyclooxygenase 1
cyclooxygenase 2
cyclooxygenase 2 inhibitor
estradiol
icosanoid
meloxicam
prostaglandin
rofecoxib
seric gonadotropin
vasculotropin
vasculotropin receptor 1
vasculotropin receptor 2
animal experiment
animal model
animal tissue
article
controlled study
drug mechanism
female
granulosa cell
immunohistochemistry
immunoreactivity
nonhuman
organ weight
ovary follicle
ovary hyperstimulation
ovary weight
priority journal
protein expression
rat
stroma cell
Wistar rat
Animals
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Down-Regulation
Female
Gene Expression
Humans
Incidence
Organ Size
Ovarian Hyperstimulation Syndrome
Ovary
Rats
Rats, Wistar
Thiazines
Thiazoles
Vascular Endothelial Growth Factor A
spellingShingle cyclooxygenase-2 inhibitor
meloxicam
Ovarian hyperstimulation syndrome
VEGF
arachidonic acid
chorionic gonadotropin
cyclooxygenase 1
cyclooxygenase 2
cyclooxygenase 2 inhibitor
estradiol
icosanoid
meloxicam
prostaglandin
rofecoxib
seric gonadotropin
vasculotropin
vasculotropin receptor 1
vasculotropin receptor 2
animal experiment
animal model
animal tissue
article
controlled study
drug mechanism
female
granulosa cell
immunohistochemistry
immunoreactivity
nonhuman
organ weight
ovary follicle
ovary hyperstimulation
ovary weight
priority journal
protein expression
rat
stroma cell
Wistar rat
Animals
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Down-Regulation
Female
Gene Expression
Humans
Incidence
Organ Size
Ovarian Hyperstimulation Syndrome
Ovary
Rats
Rats, Wistar
Thiazines
Thiazoles
Vascular Endothelial Growth Factor A
Quintana, R.
Kopcow, L.
Marconi, G.
Young, E.
Yovanovich, C.
Paz, D.A.
Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
topic_facet cyclooxygenase-2 inhibitor
meloxicam
Ovarian hyperstimulation syndrome
VEGF
arachidonic acid
chorionic gonadotropin
cyclooxygenase 1
cyclooxygenase 2
cyclooxygenase 2 inhibitor
estradiol
icosanoid
meloxicam
prostaglandin
rofecoxib
seric gonadotropin
vasculotropin
vasculotropin receptor 1
vasculotropin receptor 2
animal experiment
animal model
animal tissue
article
controlled study
drug mechanism
female
granulosa cell
immunohistochemistry
immunoreactivity
nonhuman
organ weight
ovary follicle
ovary hyperstimulation
ovary weight
priority journal
protein expression
rat
stroma cell
Wistar rat
Animals
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Down-Regulation
Female
Gene Expression
Humans
Incidence
Organ Size
Ovarian Hyperstimulation Syndrome
Ovary
Rats
Rats, Wistar
Thiazines
Thiazoles
Vascular Endothelial Growth Factor A
description Fil:Yovanovich, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
format JOUR
author Quintana, R.
Kopcow, L.
Marconi, G.
Young, E.
Yovanovich, C.
Paz, D.A.
author_facet Quintana, R.
Kopcow, L.
Marconi, G.
Young, E.
Yovanovich, C.
Paz, D.A.
author_sort Quintana, R.
title Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
title_short Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
title_full Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
title_fullStr Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
title_full_unstemmed Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
title_sort inhibition of cyclooxygenase-2 (cox-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
url http://hdl.handle.net/20.500.12110/paper_00150282_v90_n4SUPPL_p1511_Quintana
work_keys_str_mv AT quintanar inhibitionofcyclooxygenase2cox2bymeloxicamdecreasestheincidenceofovarianhyperstimulationsyndromeinaratmodel
AT kopcowl inhibitionofcyclooxygenase2cox2bymeloxicamdecreasestheincidenceofovarianhyperstimulationsyndromeinaratmodel
AT marconig inhibitionofcyclooxygenase2cox2bymeloxicamdecreasestheincidenceofovarianhyperstimulationsyndromeinaratmodel
AT younge inhibitionofcyclooxygenase2cox2bymeloxicamdecreasestheincidenceofovarianhyperstimulationsyndromeinaratmodel
AT yovanovichc inhibitionofcyclooxygenase2cox2bymeloxicamdecreasestheincidenceofovarianhyperstimulationsyndromeinaratmodel
AT pazda inhibitionofcyclooxygenase2cox2bymeloxicamdecreasestheincidenceofovarianhyperstimulationsyndromeinaratmodel
_version_ 1807323342591492096